Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,462,436 papers from all fields of science
Search
Sign In
Create Free Account
isosorbide-2-mononitrate
Known as:
isosorbide 2-nitrate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Isosorbide Dinitrate
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
J. Ratz
,
A. Fraser
,
K. Rees-Milton
,
M. Adams
,
B. Bennett
Journal of Pharmacology and Experimental…
2000
Corpus ID: 2801285
There is evidence that increased endothelial production of endothelin-1 (ET-1) may contribute to glyceryl trinitrate (GTN…
Expand
2000
2000
Packed-column supercritical fluid chromatography for the analysis of isosorbide-5-mononitrate and related compounds in bulk substance and tablets.
O. Gyllenhaal
,
A. Karlsson
Journal of Biochemical and Biophysical Methods
2000
Corpus ID: 22350309
1994
1994
Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate.
N. Mukerjee
,
R. Pietruszko
Journal of Biological Chemistry
1994
Corpus ID: 20979530
Isosorbide dinitrate inactivated E1 and E2 isozymes of human aldehyde dehydrogenase (EC 1.2.1.3), abolishing both dehydrogenase…
Expand
1990
1990
Assay of glyceryl trinitrate, isosorbide dinitrate, and their metabolites in plasma by large‐bore capillary column gas‐liquid chromatography
B. P. Booth
,
B. Bennett
,
+4 authors
K. Nakatsu
Biopharmaceutics & drug disposition
1990
Corpus ID: 23742939
Two large‐bore capillary columns, one with dimethyl polysiloxane (HP‐1®) as the stationary phase and the other with phenyl (50…
Expand
Review
1989
Review
1989
Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
W. Schaumann
International journal of clinical pharmacology…
1989
Corpus ID: 1011089
Short-acting nitrates like glyceryl trinitrate are most suitable for interrupting attacks of angina pectoris, long-acting…
Expand
1988
1988
Mechanisms for the in vivo antiplatelet effects of isosorbide dinitrate.
R. D. Caterina
,
D. Giannessi
,
Annamaria Mazzone
,
W. Bernini
European Heart Journal
1988
Corpus ID: 30024289
We investigated two possible reasons for the greater antiplatelet efficacy of isosorbide dinitrate (ISDN) in vivo as compared to…
Expand
1988
1988
Organic Nitrates: Direct Antiplatelet Effects and Synergism with Prostacyclin
Raffaele De Caterina
,
D. Giannessi
,
W. Bernini
,
Annamaria Mazzone
Thrombosis and Haemostasis
1988
Corpus ID: 21357927
Summary Isosorbide dinitrate inhibits platelet function in vivo at concentrations about 10 times lower than in vitro (10-7 -10-6…
Expand
1985
1985
Effects of Isosorbide-5-Mononitrate on Hemodynamic Parameters and on Regional Myocardial Ischemia in Conscious Dogs
K. Strein
,
V. Em
,
G. Sponer
,
B. Müller-Beckmann
,
E. Roesch
1985
Corpus ID: 69105379
Isosorbide dinitrate (ISDN) is rapidly metabolized to isosorbide-5-mononitrate (IS-5-MN) and isosorbide-2-mononitrate (IS-2-MN…
Expand
1984
1984
Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
K. Strein
,
G. Sponer
,
W. Bartsch
,
B. Müller-Beckmann
,
K. Dietmann
Journal of Pharmacology and Experimental…
1984
Corpus ID: 6064588
Whereas the clinical efficacy of isosorbide-5-mononitrate (IS-5-MN) in angina pectoris has been demonstrated unequivocally, the…
Expand
1983
1983
[Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
M. Leitold
,
H. Laufen
Arzneimittel-Forschung
1983
Corpus ID: 12744301
The effect of isosorbide 2-mononitrate (IS-2-MN) was compared with that of isosorbide dinitrate (ISDN) in rats regarding the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE